Fulton Breakefield Broenniman Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$6.6M |
| 2 |
RTN
Raytheon Company
RTN
|
+$4.46M |
| 3 |
iShares Russell 2000 Growth ETF
IWO
|
+$2.19M |
| 4 |
Chevron
CVX
|
+$1.91M |
| 5 |
iShares Russell Mid-Cap ETF
IWR
|
+$1.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$6.98M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$6.72M |
| 3 |
Sempra
SRE
|
+$5.34M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$5.13M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$3.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.22% |
| 2 | Financials | 13.16% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Staples | 8.1% |
| 5 | Consumer Discretionary | 6.53% |
Similar funds
Fulton Breakefield Broenniman's Q4 2018 Portfolio in Review
As of Q4 2018, Fulton Breakefield Broenniman held 114 positions worth $566M, down 12% from $643M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Fulton Breakefield Broenniman withdrew a net $30.1M in Q4 2018, closing 5 positions and reducing 80 holdings. Its most notable exit was Praxair Inc, an estimated $6.98M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Fulton Breakefield Broenniman opened a new position in Linde worth $6.52M.
- Fulton Breakefield Broenniman's largest Q4 2018 buy was Linde: 41,757 shares worth $6.52M.
- Fulton Breakefield Broenniman added most to Chevron in Q4 2018, an estimated $1.91M increase.
- Fulton Breakefield Broenniman's biggest Q4 2018 reduction was iShares Core S&P 500 ETF, cutting an estimated $6.72M.
- Fulton Breakefield Broenniman fully exited Praxair Inc in Q4 2018, selling an estimated $6.98M.
- Fulton Breakefield Broenniman's ten largest holdings make up 25% of its $566M portfolio in Q4 2018.
- Fulton Breakefield Broenniman opened 6 new positions and closed 5 in Q4 2018.
- Fulton Breakefield Broenniman's portfolio value fell 12% quarter-over-quarter to $566M.
Based on Fulton Breakefield Broenniman's 13F filing for Q4 2018, filed 5 Feb 2019.